Abstract
Recent studies have raised great interest in the modulation of autoimmune responses by manipulation of immunoregulatory cells. Several lymphocyte subpopulations responsible for the induction and maintenance of immune tolerance have been extensively studied, and much has been learned about their properties. Lately, a series of attempts to harness the immunoregulatory activities of these cells for therapeutic purposes has proven successful in preclinical studies. The development of new strategies for the expansion of glycolipid-induced activation of NKT cells and antigenspecific regulatory T cells represent examples that have generated considerable interest and that are leading to the development of immunoregulatory cell-based approaches translating the findings from the bench to the bedside. This review highlights the advances, obstacles and limitations of these studies and critically discusses the most recent findings in this rapidly expanding field.
Keywords: autoimmune diseases, natural killer T (NKT) cells, lipopolysaccharide (LPS), Immunoregulatory Cells, nonobese diabetic (NOD), Foxp3-deficient mice
Current Medicinal Chemistry
Title: Natural and Adaptive Immune Cell-Based Therapies in Autoimmunity
Volume: 13 Issue: 13
Author(s): Antonio L. Cava and Fu-Dong Shi
Affiliation:
Keywords: autoimmune diseases, natural killer T (NKT) cells, lipopolysaccharide (LPS), Immunoregulatory Cells, nonobese diabetic (NOD), Foxp3-deficient mice
Abstract: Recent studies have raised great interest in the modulation of autoimmune responses by manipulation of immunoregulatory cells. Several lymphocyte subpopulations responsible for the induction and maintenance of immune tolerance have been extensively studied, and much has been learned about their properties. Lately, a series of attempts to harness the immunoregulatory activities of these cells for therapeutic purposes has proven successful in preclinical studies. The development of new strategies for the expansion of glycolipid-induced activation of NKT cells and antigenspecific regulatory T cells represent examples that have generated considerable interest and that are leading to the development of immunoregulatory cell-based approaches translating the findings from the bench to the bedside. This review highlights the advances, obstacles and limitations of these studies and critically discusses the most recent findings in this rapidly expanding field.
Export Options
About this article
Cite this article as:
Cava L. Antonio and Shi Fu-Dong, Natural and Adaptive Immune Cell-Based Therapies in Autoimmunity, Current Medicinal Chemistry 2006; 13 (13) . https://dx.doi.org/10.2174/092986706777442020
DOI https://dx.doi.org/10.2174/092986706777442020 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Total Phenolic Content and In vitro Antioxidant Activity of Endophytic Fungi Isolated from Calotropis procera L.
Current Bioactive Compounds Reactive Oxygen Species in Pathogenesis of Atherosclerosis
Current Pharmaceutical Design Alzheimer’s Disease: Physical Activities as an Effective Intervention Tool - A Mini-Review
Current Alzheimer Research Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity
Current Pharmaceutical Design Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Natural Products and Cancer Stem Cells
Current Pharmaceutical Design Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier
Current Drug Metabolism Current Trends in the Application of Nanoparticles in Drug Delivery
Current Medicinal Chemistry Characterization of Protein and Peptide Stability and Solubility in Non-Aqueous Solvents
Current Pharmaceutical Biotechnology Bacterial Translocation, Microcirculation Injury and Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Toll-like Receptors in Autoimmunity
Current Drug Targets Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review
Infectious Disorders - Drug Targets Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders)
Recent Patents on CNS Drug Discovery (Discontinued) Non-Homologous DNA End Joining in Anticancer Therapy
Current Cancer Drug Targets Adverse Drug Reactions in Critical Care Settings: A Systematic Review
Current Drug Safety Recent Patent-Based Perspective on Diagnostic and Therapeutic Interventions in Malignant Mesothelioma: Is Drug Repositioning Knocking on the Door?
Recent Patents on Anti-Cancer Drug Discovery Immobilization of Proteins in Alginate: Functional Properties and Applications
Current Organic Chemistry Neuropeptide Y and Cancer Anorexia
Current Medicinal Chemistry - Central Nervous System Agents Concentration-Dependent Bimodal Effect of Specific 18 kDa Translocator Protein (TSPO) Ligands on Cell Death Processes Induced by Ammonium Chloride: Potential Implications for Neuropathological Effects Due to Hyperammonemia
CNS & Neurological Disorders - Drug Targets Targeted Vascular Drug Delivery in Cerebral Cancer
Current Pharmaceutical Design